Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Apr;32(2):140-146.
doi: 10.1097/GCO.0000000000000612.

A review of the intriguing interaction between testosterone and neurocognitive development in males with 47,XXY

Affiliations
Review

A review of the intriguing interaction between testosterone and neurocognitive development in males with 47,XXY

Carole A Samango-Sprouse et al. Curr Opin Obstet Gynecol. 2020 Apr.

Abstract

Purpose of review: Although 47,XXY (Klinefelter syndrome) was first discovered more than 50 years ago, there have been limited comprehensive studies on this disorder. The present review explains the study of neurodevelopmental dysfunction and the impact of testosterone replacement at specific junctions in the life of males with 47,XXY. The intricate relationship between testosterone, neurodevelopment, health, and well being warrants an in-depth investigation in order to achieve optimal outcomes.

Recent findings: Current literature suggests that the implementation of biological treatment has a positive impact on numerous areas of neurodevelopment. Further research is needed to determine ideal dosage, timing, and frequency of biological treatment for efficacy and safety of the child with 47,XXY.

Summary: As noninvasive prenatal screening has detected increasing numbers of fetuses with 47,XXY, parents may benefit from both prenatal and postnatal counseling, including the latest innovative biological treatment, that may further optimize the child's outcome, especially when coupled with targeted early intervention services.

PubMed Disclaimer

References

    1. Klinefelter HF, Reifenstein EC, Albright F. Syndrome characterized by gynecomastia, aspermatogenesis without A-leydigism, and increased excretion of follicle-stimulating hormone. J Clin Endocrinol Metabol 1942; 2:615–627.
    1. Maclean N, Harnden DG, CourtBrown WM. Abnormalities of sex chromosome constitution in newborn babies. Lancet 1961; 278:406–408.
    1. Perwein E. Incidence of Klinefelter's syndrome. In: Klinefelter's syndrome. Berlin: Springer; 1984. 8–11.
    1. Nielsen J, Wohlert M. Chromosome abnormalities found among 34910 newborn children: results from a 13-year incidence study in Arhus, Denmark. Hum Genet 1991; 87:81–83.
    1. Bojesen A, Juul S, Gravholt CH. Prenatal and postnatal prevalence of Klinefelter syndrome: a National Registry Study. J Clin Endocrinol Metab 2003; 88:622–626.

Publication types